
Shanghai
688180.SSShanghai Junshi Biosciences Co., Ltd. Price (688180.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
984,237,869
(7.1593)%Revenue and Profitability
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5,801,886 | 2,886,792 | 3,757,000 | 1,148,000 | 934,000 | 775,089,000 | 1,594,897,000 | 4,024,841,000 | 1,453,493,000 | 1,482,845,594 |
Net Income | -25,253,952 | -57,970,317 | -131,967,000 | -321,071,000 | -716,414,000 | -744,233,000 | -1,665,639,000 | -728,181,000 | -2,582,095,000 | -2,281,624,000 |
FCF USD | -82,093,830 | -155,030,112 | -384,996,000 | -681,002,000 | -1,068,129,000 | -2,050,183,000 | -2,091,488,000 | -1,528,129,000 | -2,169,277,000 | -2,847,539,000 |
OCF USD | -39,189,540 | -82,027,829 | -185,207,000 | -347,076,000 | -510,758,000 | -1,187,034,000 | -1,498,806,000 | -641,901,000 | -1,775,325,000 | -2,004,982,103 |
Financial Health - DEBT
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.00 | 0.00 | 0.00 | -0.55 | -1.01 | -0.34 | -0.98 | -0.33 | -0.49 |
D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.29 | 0.15 | 0.08 | 0.14 | 0.25 |
CA/CL | 20.92 | 35.35 | 28.74 | 8.73 | 6.18 | 3.16 | 3.15 | 2.89 | 4.06 | 2.25 |
TA/TL | 25.47 | 44.37 | 51.26 | 12.15 | 4.55 | 3.08 | 3.69 | 4.06 | 4.52 | 2.82 |
Total Debt | 0 | 0 | 0 | 0 | 570,395,000 | 862,965,000 | 850,779,000 | 628,195,000 | 1,321,581,000 | 1,788,567,000 |
Management Performance
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
ROIC | -13.64% | -13.38% | -13.15% | -29.78% | -17.23% | -19.08% | -24.65% | -9.27% | -22.95% | -26.37% |
ROE | -8.01% | -9.55% | -11.70% | -28.65% | -21.56% | -24.90% | -28.52% | -9.15% | -27.18% | -31.91% |
ROA | 0.00% | -9.23% | -11.46% | -26.32% | -16.85% | -17.26% | -20.84% | -5.36% | -21.27% | -21.95% |
NM % | -435.27% | -2,008.12% | -3,512.56% | -27,967.86% | -76,703.85% | -96.02% | -104.44% | -18.09% | -177.65% | -153.87% |
FCF / R% | 0.00% | -5,370.32% | -10,247.43% | -59,320.73% | -114,360.71% | -264.51% | -131.14% | -37.97% | -149.25% | -192.03% |
FCF / NI% | 325.07% | 267.43% | 292.27% | 212.14% | 148.85% | 268.66% | 125.28% | 257.85% | 81.09% | 114.36% |
Operating Margin (OM) | 0.00 | -23.11 | -52.71 | -452.41 | -1,330.07 | -2.57 | -2.30 | -1.09 | -4.66 | -6.11 |
Per Share
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
EPS | -0.12 | -0.26 | -0.17 | -0.42 | -1.19 | -0.95 | -1.91 | -0.82 | -2.81 | -2.32 |
SPS | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.99 | 1.83 | 4.52 | 1.58 | 1.51 |
OCPS | -0.18 | -0.37 | -0.24 | -0.46 | -0.85 | -1.51 | -1.72 | -0.72 | -1.93 | -2.04 |
FCPS | -0.38 | -0.70 | -0.51 | -0.90 | -1.77 | -2.61 | -2.40 | -1.72 | -2.36 | -2.89 |
BVPS | 1.49 | 2.75 | 1.48 | 1.47 | 5.52 | 3.81 | 6.69 | 9.36 | 10.66 | 7.44 |
Per Share - CAGR
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | -0.12 | -0.26 | -0.17 | -0.42 | -1.19 | -0.95 | -1.91 | -0.82 | -2.81 | -2.32 |
CAGR-SPS | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.99 | 1.83 | 4.52 | 1.58 | 1.51 |
CAGR-OCPS | -0.18 | -0.37 | -0.24 | -0.46 | -0.85 | -1.51 | -1.72 | -0.72 | -1.93 | -2.04 |
CAGR-FCPS | -0.38 | -0.70 | -0.51 | -0.90 | -1.77 | -2.61 | -2.40 | -1.72 | -2.36 | -2.89 |
CAGR-BVPS | 1.49 | 2.75 | 1.48 | 1.47 | 5.52 | 3.81 | 6.69 | 9.36 | 10.66 | 7.44 |